AI-Controlled Chemical Compound Delivery Based on Trust Dynamics

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional chemical compound delivery systems are limited by predefined constraints that do not account for individual patient characteristics, leading to potential denial of medication during periods of need, as they rely solely on the properties of the medication without considering the patient's trust dynamics and responsiveness.

Innovation Solution

A system utilizing artificial intelligence to assess and autonomously control the delivery of chemical compounds based on a trust disposition value, determined through machine learning technology, which considers the patient's trust dynamics and responsiveness to optimize medication distribution.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional predefined constraints are used to control chemical compound delivery, then system simplicity is maintained, but treatment effectiveness deteriorates due to inability to account for individual patient characteristics

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidsystem complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The system implements feedback loops where patient responses to chemical compounds are continuously monitored and fed back into the machine learning model. This feedback mechanism allows the system to learn from patient reactions and dynamically adjust future delivery decisions, thereby improving treatment effectiveness while managing complexity through automated learning processes.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The machine learning system performs self-adjustment by automatically learning optimal delivery parameters from accumulated patient data without requiring manual reconfiguration. The system serves itself by continuously training the model on new data, enabling it to adapt to individual patient characteristics autonomously and improve treatment effectiveness over time.

Inventive Principle:
Principle #25Self-service

2Reliability

If machine learning technology is implemented to assess trust dynamics, then treatment effectiveness is improved through personalized delivery, but device complexity increases

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidsystem complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The system replaces complex manual assessment mechanisms with machine learning algorithms that automatically analyze patient data and trust dynamics. This substitution transforms the complexity from mechanical/operational to computational, allowing the system to handle sophisticated personalized decision-making through software rather than hardware complexity.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The machine learning model serves multiple functions: it assesses patient trust dynamics, predicts treatment responsiveness, determines optimal chemical compound delivery parameters, and continuously learns from new data. This multi-functionality consolidates multiple complex tasks into a single unified system, improving treatment effectiveness without proportionally increasing overall system complexity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Manufacturing precision

If autonomous control based on trust disposition is implemented, then medication delivery precision is improved, but ease of operation deteriorates due to reduced manual intervention

Engineering Contradiction:
Improvemedication delivery precisionVSAvoidoperational simplicity
Core Design Contradiction:
Manufacturing precisionVSEase of operation

Solution Approach 1:

The system achieves autonomous operation where the machine learning model automatically determines chemical compound delivery parameters based on patient trust dynamics without requiring manual intervention. The system serves itself by continuously learning and adapting, thereby achieving high delivery precision while minimizing the need for operator involvement in decision-making processes.

Inventive Principle:
Principle #25Self-service

Data Source

PatentUS11557398B2Delivering a chemical compound based on a measure of trust dynamics
Publication Date: 2023.01.17 INTERNATIONAL BUSINESS MACHINE CORPORATION
  • US11557398B2 patent drawing
  • US11557398B2 patent drawing
  • US11557398B2 patent drawing

AI summary

Techniques regarding autonomously controlling the delivery of one or more chemical compounds are provided. For example, one or more embodiments described herein can comprise a system, which can comprise a memory that can store computer executable components. The system can also comprise a processor, operably coupled to the memory, and that can execute the computer executable components stored in the memory. The computer executable components can comprise a compound component can identify a chemical compound mixture to be distributed to an entity based on a trust disposition value. The trust disposition value can be determined using machine learning technology and is indicative of an expected effectiveness of the chemical compound mixture with regards to the entity.